Akso Health Group (AHG) › Cash & EquivalentsAkso Health Group (AHG) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2015: $954.7K2016: $7.82M2017: $19.23M2018: $132.62M2019: $57.37M2020: $6.67M2021: $15.13M2022: $18.43M2023: $7.92M2024: $85.17M2025: $176.23M2026: $170.6K$170.6K2015Cash & Equivalents (USD)2026Fiscal YearCash & EquivalentsChange YoY2026$170.6K-99.9%2025$176.23M+106.9%2024$85.17M+974.8%2023$7.92M-57.0%2022$18.43M+21.8%2021$15.13M+126.9%2020$6.67M-88.4%2019$57.37M-56.7%2018$132.62M+589.6%2017$19.23M+146.0%2016$7.82M+719.0%2015$954.7K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share